• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2023 Oct 25:ciad618.
doi: 10.1093/cid/ciad618. Online ahead of print. A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores

Katharina S Appel[SUP] 1 [/SUP], Ramsia Geisler[SUP] 1 [/SUP], Daniel Maier[SUP] 1 2 [/SUP], Olga Miljukov[SUP] 3 [/SUP], Sina M Hopff[SUP] 4 [/SUP], Jörg J Vehreschild[SUP] 1 4 5 [/SUP]



Affiliations
Abstract

Background: Numerous prognostic scores have been published to support risk stratification for patients with Coronavirus disease 2019 (COVID-19).
Methods: We performed a systematic review to identify the scores for confirmed or clinically assumed COVID-19 cases. An in-depth assessment and risk of bias (ROB) analysis (Prediction model Risk Of Bias ASsessment Tool (PROBAST)) was conducted for scores fulfilling predefined criteria ((I) area under the curve (AUC) ≥ 0.75; (II) a separate validation cohort present; (III) training data from a multicenter setting (≥ 2 centers); (IV) point-scale scoring system).
Results: Out of 1,522 studies extracted from MEDLINE/Web of Science (20/02/2023), we identified 242 scores for COVID-19 outcome prognosis (mortality 109, severity 116, hospitalization 14, long-term sequelae 3). Most scores were developed using retrospective (75.2%) or single-center (57.1%) cohorts. Predictor analysis revealed the primary use of laboratory data and sociodemographic information in mortality and severity scores. Forty-nine scores were included in the in-depth analysis. The results indicated heterogeneous quality and predictor selection, with only five scores featuring low ROB. Among those, based on the number and heterogeneity of validation studies, only the 4C Mortality Score can be recommended for clinical application so far.
Conclusion: The application and translation of most existing COVID scores appear unreliable. Guided development and predictor selection would have improved the generalizability of the scores and may enhance pandemic preparedness in the future.

Keywords: COVID-19; Pandemic preparedness; Prediction models; Predictors; Scores.

 
Back
Top